Clinical Trial Update: Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis [NA]

View source ↗

Summary

A post-approval study for Lixelle to treat dialysis-related amyloidosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dialysis-related Amyloidosis

Drugs mentioned

• Lixelle

Snippet

Sponsor: Kaneka Medical America LLC | Conditions: Dialysis Amyloidosis | NA | Status: RECRUITING